Dadullah Faiz

Dr. Dadullah Faiz

Department of Internal Medicine, Kandahar University, Kandahār, Afghanistan
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2026 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
AAAbu-Bakr Ahmed
Abu-Bakr Ahmed
SKSakshi Kumari
Sakshi Kumari
AHAnid Hassan
Anid Hassan
SASyed Hassan Ali
Syed Hassan Ali
AGAnirudh Govind
Anirudh Govind
AKArbab Khalid
Arbab Khalid
e19039 Background: Hodgkin lymphoma is a curable malignancy, the choice of frontline therapy for advanced-stage disease remains debated. ABVD has been the backbone of treatment for decades because of its reliable efficacy and lower long-term toxicity, while escalated BEACOPP was introduced to improve disease control. Randomized trials show better progression-free survival with BEACOPP but no clear overall survival benefit. BEACOPP carries higher rates of acute toxicity, infertility, and secondary malignancies particularly relevant given patients' young age and long life expectancy. Interpretation of existing literature is limited by differences in study design, patient selection, follow-up duration, and outcome reporting, so many individual trials are underpowered. A systematic review and meta-analysis is needed to define balance between efficacy and toxicity in advanced Hodgkin lymphoma. Methods: A total of 2858 records were retrieved from PubMed, Embase, Scopus, ScienceDirect, and the Cochrane Library from inception January 2026. Eligible randomized controlled trials and comparative observational studies of frontline BEACOPP (standard/escalated) vs ABVD in classical Hodgkin lymphoma reporting overall survival (OS) and progression-free/event-free survival (PFS/EFS), while secondary outcomes included complete or objective response, treatment-related toxicity (including grade 3–4 adverse events), secondary malignancies, and treatment discontinuation due to adverse events, and health-related. Pooled analyses used RevMan random-effects models (p<0.05). Results: Eight studies (n = 5187) assessed the effectiveness of BEACOPP compared to ABVD in patients with classical Hodgkin lymphoma receiving front-line systemic therapy. BEACOPP showed an 18% reduction in the risk of mortality (HR 0.82; 95% CI 0.48–1.41; p = 0.48) and a 38% reduction in the risk of progression (HR 0.62; 95% CI 0.45–0.85; p = 0.003), with moderate heterogeneity (I² = 55%). However, no significant differences were observed in complete response rate (RR 0.99; 95% CI 0.89–1.10; p = 0.82) or overall response rate (RR 1.03; 95% CI 0.95–1.11; p = 0.51) with heterogeneity (I² = 51% and 23%, respectively). BEACOPP was associated with a significantly higher risk of serious adverse events (RR 4.60; 95% CI 2.37–8.93; p = 0.04) and a higher risk of secondary malignancies (RR 1.30; 95% CI 0.47–3.58; p = 0.61), both reported with moderate heterogeneity (I² = 65% and 71%). Additionally, BEACOPP showed a non-significant reduction in the risk of event occurrence (HR 0.36; 95% CI 0.07–1.93; p = 0.23), though this result was limited by high heterogeneity (I² = 97%). Conclusions: BEACOPP improved progression free survival as compared to ABVD but did not significantly improve overall survival and was associated with significantly greater toxicity. This efficacy toxicity trade off must be put into close consideration with regimen choice.

31 May 2026 in Clinical Case Reports
Verified
Journal Article
Open access
MSMuhammad Ibrahim Shah
Muhammad Ibrahim Shah
HSHasnain Wajeeh Saqib
Hasnain Wajeeh Saqib
MKMaaz Khan
Maaz Khan
MSMuhammad Saeed Ullah Shah
Muhammad Saeed Ullah Shah
DFDadullah Faiz
Dadullah Faiz
Peripartum cardiomyopathy (PPCM) is defined as the onset of left ventricular systolic dysfunction either during pregnancy or up to 5 months after delivery, without any other known cause of heart failure. The exact pathogenesis of this disease is unknown, and its prognosis remains poorly understood. We present a case of a 27‐year‐old woman presenting at 37 + 3 weeks of gestation, with reduced ejection fraction, biventricular systolic dysfunction and dilation, and valvular regurgitation. She was managed with medications slightly different from guideline‐mediated standard therapy. The unique and most crucial detail of this case is that it showed a close family history of PPCM, as the patient's older sister had also died of the same cause. Learning objectives: genetic and familial risk of developing peripartum cardiomyopathy.

23 September 2026 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
MSMifrah Rahat Khan Sherwani
Mifrah Rahat Khan Sherwani
FKFilza Rahat Khan
Filza Rahat Khan
YRYoussef Ramadan
Youssef Ramadan
DBDua Bashir
Dua Bashir
ABAisha Bashir
Aisha Bashir
MHMohamed Fawzi Hemida
Mohamed Fawzi Hemida

9 October 2026 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
ADAshesh Das
Ashesh Das
Mohamed N. ElshabrawiMohamed N. Elshabrawi
Mohamed N. Elshabrawi
KKKrish Keswani
Krish Keswani
RMRaveen Muzaffer
Raveen Muzaffer
CNChennuri Nandan
Chennuri Nandan
HAHaroon Alamy
Haroon Alamy
Immune checkpoint inhibitors (ICIs) have fundamentally transformed modern oncology by unleashing the body’s anti-tumor immunity, yet people living wi

1 June 2026 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
FKFaiza Khalid
Faiza Khalid
RCRaj Nandan Chennuri
Raj Nandan Chennuri
ACAdithya Chandran
Adithya Chandran
HKHrishikesh Kommu
Hrishikesh Kommu
DFDadullah Faiz
Dadullah Faiz
RBRutuja Prakash Batwal
Rutuja Prakash Batwal
e16148 Background: Post-procedural bleeding remains a significant complication following gastric endoscopic submucosal dissection (ESD), occurring in up to 15% of cases. Fibrin glue has been proposed as a protective barrier to mitigate this risk. We conducted a meta-analysis of randomized controlled trials (RCTs) to synthesize current evidence regarding the efficacy of fibrin glue in preventing post-ESD bleeding. Methods: A systematic review identified three RCTs (Kim 2025, Lee 2023, Kataoka 2019) comparing fibrin glue application versus standard care in patients undergoing gastric ESD. A total of 636 patients were included (318 fibrin glue; 318 standard care). The primary outcome was overall post-ESD bleeding within 4 weeks. Secondary outcomes included acute ( < 24 hours) and delayed ( > 24 hours) bleeding. Pooled risk ratios (RR) were calculated using random-effects models. Results: The analysis revealed no significant reduction in overall post-ESD bleeding with fibrin glue compared to control (9.7% vs. 10.7%; RR 0.91, 95% CI 0.57–1.44). Heterogeneity for the primary outcome was negligible (I 2 = 0.0%), indicating highly consistent findings across studies. Furthermore, no significant differences were observed in secondary outcomes, including acute bleeding (RR 0.72, 95% CI 0.15–3.44) or delayed bleeding (RR 1.11, 95% CI 0.52–2.36). While acute bleeding rates were numerically lower in the intervention group (3.9% vs. 5.5%), this did not reach statistical significance. Conclusions: Based on high-quality evidence from recent RCTs, prophylactic fibrin glue application does not significantly reduce bleeding rates following gastric ESD. The data suggest that routine use of fibrin glue is unwarranted in the general patient population. Future research should pivot toward identifying specific high-risk subgroups that may derive benefit, rather than unselected prophylaxis.

1 June 2026 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
AAAyesha Arif
Ayesha Arif
SKSakshi Kumari
Sakshi Kumari
NSNabahat Shafi
Nabahat Shafi
SASyed Hassan Ali
Syed Hassan Ali
SSShanza Shakir
Shanza Shakir
LKLove Kumar
Love Kumar
e20690 Background: Among pollutants, exposure to cooking-related household air pollution (HAP) is a significant environmental health concern, particularly problematic for women who are non-smokers but still face a rising incidence of non-small cell lung cancer (NSCLC). However, globally, tobacco is the leading cause of cancers, but a substantial number of lung cancer cases have been reported among women, especially from low-income countries, who never smoked. Ultimately, our systematic review and meta-analysis focus on investigating the association between various cooking-related pollutants, such as cooking oil fumes and biomass fuel combustion, and risk for the development of NSCLC among these women. The pooled data will provide clarification of the impact of indoor smoking environmental pollutants on lung cancer etiology in never-smoking women. Methods: This systematic review and meta-analysis followed PRISMA guidelines and registered with PROSPERO. A total of 1901 articles were retrieved using databases including PubMed, Scopus, and EMBASE from inception to January 2026. Eligible studies evaluating the impact of exposure to cooking-related household air pollution (HAP) on the occurrence of non-small cell lung carcinoma among non-smoking adult women ≥18 years, compared with women unexposed to HAP were included. Data were analyzed using RevMan version 5.4 with a random-effects model to estimate pooled odd ratios (ORs) with 95% confidence intervals. A p-value < 0.05 was considered statistically significant. Results: Our systematic review and meta-analysis pooled results demonstrated a visible link between indoor pollution exposure and lung cancer. HAP exposure showed no significant association with lung cancer vs. healthy controls (OR: 0.66; 95% CI: 0.25-1.76, P = 0.41). Although limited by high heterogeneity (I2 = 99%), these results reflect variation in individuals across the globe. From the structural analysis of event sizes, we deduced that HAP exposure led to 1.51 times more chance of acquiring lung cancer (OR: 1.51; 95% CI: 1.25, 1.81; I2 = 20%; P < 0.0001). Our findings were verified from the reported HR: 2.04 (95% CI: 1.47, 2.82; I2 = 0%; P < 0.0001), indicating that exposed individuals had twice the chance of lung cancer being diagnosed. Conclusions: This systematic review and meta-analysis substantiates cooking-related household air pollution as an important etiologic factor in lung cancer among never-smoking women, implicating indoor combustion byproducts and supporting targeted public health interventions.